Related Experiment Video
Updated: Jan 15, 2026

07:23
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
3.2K
Relationship Between COVID-19 and Retinal Vein Occlusions
Tetsuya Muto1,2,3, Shigeki Machida1, Shinichiro Imaizumi2
1Department of Ophthalmology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Journal of Ophthalmology
|October 8, 2025
Summary
Coronavirus disease 2019 (COVID-19) infection may increase the risk of retinal vein occlusions (RVOs). Ophthalmologists should consider COVID-19 as a cause of acute vision loss and RVOs.
Area of Science:
- Ophthalmology
- Vascular Biology
- Infectious Diseases
Background:
- Retinal vein occlusions (RVOs) are a significant cause of vision loss.
- The association between COVID-19 and RVOs is not fully understood.
- COVID-19 infection is linked to endothelial dysfunction and hypercoagulability.
Purpose of the Study:
- To explore the relationship between COVID-19 and retinal vein occlusions.
- To understand the potential mechanisms linking SARS-CoV-2 infection to RVOs.
- To emphasize the importance of considering COVID-19 in patients with acute vision loss.
Main Methods:
- Review of existing literature on COVID-19 and RVOs.
- Analysis of pathophysiological mechanisms of RVOs in the context of COVID-19.
- Discussion of clinical implications for ophthalmologists.
Main Results:
- COVID-19 infection can lead to endothelial dysfunction and elevated von Willebrand factor (VWF) levels.
- These changes promote coagulation and platelet aggregation, increasing thrombosis risk.
- Venous compression at arterial-venous crossings in the retina can exacerbate clot formation.
Conclusions:
- COVID-19 is a potential etiological factor for retinal vein occlusions.
- Elevated VWF levels in COVID-19 patients contribute to thrombosis risk.
- Ophthalmologists should consider COVID-19 in patients presenting with acute vision loss and RVOs.
Keywords:
branch retinal vein occlusioncentral retinal vein occlusioncoronavirus disease 2019severe acute respiratory syndrome coronavirus 2More Related Videos
Related Concept Videos
Photoreceptors and Visual Pathways
8.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.7K
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Open Angle Glaucoma: Treatment
961
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
961

